Stokes Frank sold CSTL

March 4, 2026 · Form 4 insider transaction

Stokes Frank sold 10,732 shares of Castle Biosciences, Inc. at $28.17 per share, a transaction worth $302.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.